Naloxone use by Aotearoa New Zealand emergency medical services, 2017-2021.

Eeva-Katri Kumpula Verity Frances ToddDavid O'ByrneBridget L Dicker Adam C Pomerleau

Published in: Emergency medicine Australasia : EMA (2023)

A national rate of EMS naloxone patients was established; measured clinical effects of naloxone were modest, suggesting many patients had reasons other than opioid toxicity contributing to their symptoms. Naloxone administration rates provide indirect surveillance information about suspected harmful opioid exposures but need to be interpreted with care.

Keyphrases

end stage renal disease
healthcare
ejection fraction
chronic kidney disease
newly diagnosed
pain management
chronic pain
emergency medical
primary care
prognostic factors
public health
palliative care
quality improvement
pulmonary embolism
depressive symptoms
health insurance